Tano, Charlie M.

HRN: 28-56-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
CEFTRIAXONE 1G (VIAL)
02/13/2026
02/20/2026
IV
2g
OD
Lacerated Wound And Abrasions
Remove - Pending Acceptance
02/13/2026
MUPIROCIN 2%, 15G (TUBE)
02/13/2026
02/20/2026
TOPICAL
2%
Q12
Lacerated Wound And Abrasions
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: